Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) study

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 3, 2004, Pages 286-291

  Burns, Jason L ^a   Sears, Samuel F ^a   Sotile, Rebecca ^a   Schwartzman, David S ^b   Hoyt, Robert H ^c   Alvarez, Luis G ^d   Ujhelyi, Michael R ^e  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c IOWA HEART CENTER   (United States)

^d Orlando Heart Center   (United States)

^e MEDTRONIC INC   (United States)

Author keywords

Atrial fibrillation; Implantable cardiac device; Patient acceptance; Quality of life

Indexed keywords

ADULT; AGED; ANXIETY; DEFIBRILLATOR; DEPRESSION; DEVICE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PATIENT ATTITUDE; PATIENT SELECTION; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATTITUDE TO DEATH; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHOMETRICS; QUALITY OF LIFE; SELF CONCEPT; SICKNESS IMPACT PROFILE; STATISTICS; TREATMENT OUTCOME;

EID: 1842479818     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2004.03406.x     Document Type: Review

References (14)

1. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ: Epidemiology and natural history of atrial fibrillation: Clinical implications. J Am Coll Cardiol 2001;37:371-378.
2. Gold MR, Sulke N, Schwartzman DS, Mehra R, Euler DE: Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001;12:1247-1253.
3. Newman DM, Dorian P, Paquette M, Sulke N, Gold MR, Schwartzman DS, Schaaf K, Wood K, Johnson L: Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life. Am Heart J 2003;145:841-846.
4. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, Camm J, Akhtar M, Luderitz B: The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy. J Am Coll Cardiol 2000;36:1303-1309.
5. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
6. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
7. Ware JE Jr, Kosinski MA: SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1. Second Edition. Lincoln, RI: QualityMetric Incorporated.
8. Radloff LS, Rae DS: Susceptibility and precipitating factors in depression: sex differences and similarities. J Abnorm Psychol 1979;88:174-181.
9. King FJ, Heinrich DL, Stephenson RS, Spielberger CD: An investigation of the causal influence of trait and state anxiety on academic achievement. J Educ Psychol 1976;68:330-334.
10. Spielberger CD, Vagg PR: Psychometric properties of the STAI: A reply to Ramanaiah, Franzen, and Schill. J Pers Assess 1984;48:95-97.
11. Devins GM, Edworthy SM, Seland TP, Klein GM, Paul LC, Mandin H: Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Ment Dis 1993;181:377-381.
12. Burns JL, Walker RL, Sotile RO, Serber ER, Sears SF: Measuring patient acceptance of implantable cardiac device therapy: Initial psychometric investigation of the Florida Patient Acceptance Survey (F-PAS). (Submitted).
13. Sears SF Jr, Conti JB: Quality of life and psychological functioning of ICD patients. Heart 2002;87:488-493.
14. Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-2217.